123). It is actually notable that GLS2 is tumorigenic in breast cancer124, and its expression could compensate for lack of Gls in MYC-induced mouse liver tumours40. This implies that GLS2 could confer resistance to GLS1-precise inhibitors, including the allosteric inhibitor BPTES or CB-839, and this resistance can be hypothetically prevented https://sinefungin22108.estate-blog.com/28654364/the-basic-principles-of-e-64